Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Flaxman A. et al, (2021), Lancet, 398, 981 - 990
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
Frater J. et al, (2021), Lancet hiv, 8, e474 - e485
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Emary KRW. et al, (2021), Lancet, 397, 1351 - 1362
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Barrett JR. et al, (2021), Nat med, 27, 279 - 288
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Ewer KJ. et al, (2021), Nat med, 27, 270 - 278
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Folegatti PM. et al, (2020), Lancet, 396, 467 - 478
Physiotherapy rehabilitation for osteoporotic vertebral fracture-a randomised controlled trial and economic evaluation (PROVE trial).
Barker KL. et al, (2020), Osteoporos int, 31, 277 - 289
Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT.
Barker KL. et al, (2019), Health technol assess, 23, 1 - 318
Storage of washed or irradiated red cells in AS-7 improves their in vitro characteristics.
Proffitt S. et al, (2015), Vox sang, 109, 203 - 213
Loss of Fibulin-2 Expression Is Associated with Breast Cancer Progression
Yi C-H. et al, (2007), The american journal of pathology, 170, 1535 - 1545
Metallothioneins and resistance to cisplatin and radiation in prostate cancer
Smith DJ. et al, (2006), Urology, 67, 1341 - 1347
Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer☆
Lewis TE. et al, (2005), Urologic oncology: seminars and original investigations, 23, 407 - 412
E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.
Jaggi M. et al, (2005), Cancer res, 65, 483 - 492
Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model
Balaji KC. et al, (2004), Urologic oncology: seminars and original investigations, 22, 313 - 320
Identification of two novel elements involved in human MUCI gene expression in vivo.
Shiraga T. et al, (2002), Mol med, 8, 33 - 41
Ovine male genital duct epithelial cells differentiate in vitro and express functional CFTR and ENaC.
Bertog M. et al, (2000), Am j physiol cell physiol, 278, C885 - C894
Ovine male genital duct epithelial cells differentiate in vitro and express functional CFTR and ENaC
Bertog M. et al, (2000), American journal of physiology-cell physiology, 278, C885 - C894